Niowave Breaks Ground on New $75 Million Production Facility to Advance Targeted Cancer Therapies

The new facility positions Niowave to meet global demand for Actinium‑225 and support growing pipeline of partners developing next-generation radiopharmaceuticals LANSING, Mich., May 21, 2026 /PRNewswire/ -- Niowave today announced the groundbreaking of a new $75 million production...